Davidson & Garrard’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Davidson & Garrard's PFE Position: Q3 2017 in Review
Davidson & Garrard reduced its Pfizer (PFE) stake by 11% in Q3 2017, selling an estimated $470K and leaving 121,896 shares worth $4.13M. The position accounts for 0.97% of the portfolio, ranked #38.
Davidson & Garrard first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. The position peaked at $5.82M in Q3 2016. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.
- Davidson & Garrard held 121,896 shares of Pfizer worth $4.13M as of Q3 2017.
- Davidson & Garrard sold 14,624 Pfizer shares in Q3 2017, an estimated $470K.
- Pfizer made up 0.97% of Davidson & Garrard's portfolio in Q3 2017, its #38 holding.
- Davidson & Garrard first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
- Davidson & Garrard's Pfizer position peaked at $5.82M in Q3 2016.
- 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.
Based on Davidson & Garrard's 13F filing for Q3 2017, filed 7 Nov 2017.